BIOTRICITY INC.

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows 424B3 in the pre-IPO sequence.

2025-12-19 · 0001493152-25-028614

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

2024-05-28 · 0001493152-24-021452

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2024-05-16 · 0001493152-24-020308

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows RW and marks the registration effective.

2024-05-15 · 9999999995-24-001541

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows EFFECT and marks the registration effective.

2024-05-15 · 9999999995-24-001542

RW withdrawn

Withdrawal request

Issuer requested withdrawal of the registration statement.

Follows 424B3 and ends the active registration process.

2024-04-25 · 0001493152-24-015890

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows S-1 and confirms the priced prospectus.

2024-04-23 · 0001493152-24-015610

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows 424B5 in the pre-IPO sequence.

2024-02-28 · 0001493152-24-008031

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

2023-09-19 · 0001493152-23-033089

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B5 and confirms the priced prospectus.

2023-07-21 · 0001493152-23-025139

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2022-04-27 · 0001493152-22-011334

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 424B3 and marks the registration effective.

2022-04-25 · 9999999995-22-001073

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B5 and confirms the priced prospectus.

2022-03-22 · 0001493152-22-007474

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows 424B5 and confirms the priced prospectus.

2021-08-30 · 0001493152-21-021497

CERT inactive

CERT

Pre-IPO filing captured from the SEC submission timeline.

Follows EFFECT in the pre-IPO sequence.

2021-08-25 · 0001354457-21-000967

8-A12B effective

Exchange Act registration

Registration filed to list the securities under the Exchange Act ahead of trading.

Follows CERT and registers the class of securities for exchange listing.

2021-08-25 · 0001493152-21-021221

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows 8-A12B and confirms the priced prospectus.

2021-08-25 · 0001493152-21-021239

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 424B5 and marks the registration effective.

2021-05-04 · 9999999995-21-001785

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

2018-06-28 · 0001511164-18-000405

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2018-03-13 · 0001511164-18-000145

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows S-1/A and marks the registration effective.

2018-03-09 · 9999999995-18-000579

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1 filing.

2018-03-08 · 0001511164-18-000135

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows 424B5 in the pre-IPO sequence.

2018-02-09 · 0001511164-18-000071

424B5 priced

Final prospectus supplement

Prospectus supplement filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2017-12-26 · 0001511164-17-000782

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 424B3 and marks the registration effective.

2017-12-19 · 9999999995-17-003275

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2017-08-16 · 0001511164-17-000523

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows S-1/A and marks the registration effective.

2017-08-14 · 9999999995-17-002110

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

2017-08-11 · 0001511164-17-000483

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

2017-08-10 · 0001511164-17-000475

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

2017-07-25 · 0001511164-17-000411

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

2017-05-05 · 0001511164-17-000246

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

2017-01-13 · 0001511164-17-000019

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

2016-12-13 · 0001511164-16-001210

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $1.91 · 22,877,450 shares

Common Stock, $.001 par value · Exchange OTCQB · Ticker BTCY · 403,059 shares underlying outstanding common stock purchase warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises to fund operations · Flags warrants

Biotricity Inc. filed an S-1/A registration statement for a proposed offering of 22,877,450 shares of common stock, including shares from exchangeable shares, outstanding shares, and warrants. The company, formerly Metasolutions, Inc., rebranded and expanded its share authorization. The filing includes a 510(k) FDA clearance for its Bioflux software, pending final testing and FDA submission. The company is an emerging growth company with reduced reporting requirements.

2016-11-08 · 0001511164-16-001109

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $1.91 · 22,877,450 shares · Gross proceeds $364,582

Common Stock, $.001 par value · Exchange OTCQB · Ticker BTCY · 403,059 shares of common stock underlying outstanding common stock purchase warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes

Biotricity Inc. is registering 22,877,450 shares of common stock for sale by selling stockholders, including shares from exchangeable shares of an indirect subsidiary, outstanding common stock, and warrants. The company has not generated revenue since inception and expects to remain unprofitable. Proceeds from warrant exercises will benefit the company, while selling stockholders receive net proceeds. The filing includes risk factors related to limited operating history, regulatory uncertainties, and reliance on key personnel.

2016-09-30 · 0001511164-16-001052

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1 filing.

Price $1.91 · 22,877,450 shares

Common Stock, $.001 par value · Exchange OTCQB · Ticker BTCY · Includes shares underlying convertible debentures and common stock purchase warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises

Biotricity Inc. is registering up to 22,877,450 shares of common stock for sale by selling stockholders, including exchangeable shares, convertible debentures, and warrants. The company will not receive proceeds from stock sales but expects $364,582 from warrant exercises. The filing highlights risks related to limited operating history, regulatory approvals, competition, and speculative nature of the stock. The company is an emerging growth company with no history of profitable operations.

2016-08-22 · 0001511164-16-001004

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows 424B3 in the pre-IPO sequence.

Price $1.91 · 24,192,735 shares

Common Stock · Exchange OTCQB · Ticker BTCY · Outstanding common stock purchase warrants and convertible debentures · Selling stockholders only · Use of proceeds Selling stockholders will sell shares, no issuer proceeds · Flags warrants

Biotricity Inc. is registering 24,192,735 shares of common stock, including shares from exchangeable shares, convertible debentures, and warrants. The offering is for selling stockholders, with no proceeds going to the company except from warrant exercises. The company is quoted on OTCQB and is an emerging growth company. Risks include market volatility, dependence on key personnel, and financial uncertainties.

2016-04-26 · 0001511164-16-000786

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

Price $0.01 · Range $0.01 to $0.01 · 4,500,000 shares · Gross proceeds $45,000

COMMON STOCK · Use of proceeds Proceeds will be held in a trust account pending completion of the offering. · Flags self_underwritten, best_efforts · Underwriters self-underwritten

MetaSolutions, Inc. is offering up to 4,500,000 shares of common stock at $0.01 per share through a self-underwritten, best-efforts offering led by its founder and CEO, Peter McGoldrick. The offering has no minimum share requirement, with proceeds held in an escrow account managed by Krueger LLP. The company, an emerging growth company, has limited financial resources, no revenue, and operates in a development stage with no established market for its shares. The offering emphasizes reliance on the CEO's personal network for sales and includes risks related to liquidity, operational viability, and lack of market demand.

2015-05-27 · 0001078782-15-000904

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows S-1/A and marks the registration effective.

MetaSolutions, Inc. (now known as BIOTRICITY INC.) filed a Form S-1 registration statement for a self-underwritten offering of 4.5 million shares of common stock at $0.01 per share. The offering is conducted on a best-efforts basis by the founder, Peter McGoldrick, with no minimum share requirement. Proceeds will be held in an attorney-client trust account, and the offering is valid for 180 days. The company has limited financial resources, no established market for shares, and operates as an emerging growth company with significant risks related to liquidity, lack of revenue, and dependence on the founder's efforts.

2015-05-19 · 9999999995-15-001396

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $0.01 · Range $0.01 to $0.01 · 4,500,000 shares · Gross proceeds $45,000

Common Stock · Use of proceeds Proceeds will be held in a trust account pending completion of the offering · Flags self_underwritten, best_efforts · Underwriters self-underwritten

MetaSolutions, Inc. is offering up to 4,500,000 shares of common stock at $0.01 per share in a self-underwritten, best-efforts offering with no minimum. The company, incorporated in 2012, focuses on developing energy management software but has not yet generated revenue. It relies on founder Peter McGoldrick's efforts, has limited financial resources, and faces uncertainties in product development and market viability. The offering is conducted through a non-interest-bearing escrow account, with proceeds intended for business operations.

2015-05-05 · 0001078782-15-000696

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $0.01 · 4,500,000 shares · Gross proceeds $45,000

Common Stock · Selling stockholders only · Use of proceeds Proceeds to be held in trust pending completion of the offering · Underwriters self-underwritten

MetaSolutions, Inc. is offering up to 4,500,000 shares of common stock at $0.01 per share in a self-underwritten, best-efforts offering with no minimum share requirement. The company, incorporated in 2012, focuses on developing energy management software and services but has not generated revenue. It relies on its founder, Peter McGoldrick, for management and has limited financial resources. The offering is subject to completion and will last 180 days unless extended.

2015-04-17 · 0001078782-15-000597

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1 filing.

Price $0.01 · 4,500,000 shares · Gross proceeds $45,000

Common stock, $0.001 par value per share · Use of proceeds Proceeds will be held in a trust account pending the completion of the offering · Flags self_underwritten, best_efforts · Underwriters self-underwritten

MetaSolutions, Inc. is offering up to 4,500,000 shares of common stock at $0.01 per share, self-underwritten by founder Peter McGoldrick. The company, in the development stage, focuses on energy management software but has not yet generated revenue or developed a saleable product. Shares are illiquid with no established market. The company is an emerging growth company with reduced reporting requirements.

2015-03-12 · 0001078782-15-000377

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

First tracked pre-IPO filing for this issuer.

Price $0.01 · Range $0.01 to $0.01 · 4,500,000 shares · Gross proceeds $45,000

Common Stock · Use of proceeds Working capital and general corporate purposes · Underwriters self-underwritten

MetaSolutions, Inc. (MSI) is offering up to 4,500,000 shares of common stock at $0.01 per share in a self-underwritten, best-efforts offering led by its founder, Peter McGoldrick. The company, incorporated in 2012, has no revenue, limited financial resources, and has not developed a saleable product. Proceeds will go to a trust account, with no public market for shares. MSI operates as an emerging growth company with significant risks including reliance on its founder, unproven business model, and auditor concerns about its ability to continue as a going concern.

2015-01-27 · 0001078782-15-000118

BIOTRICITY INC.

Filing Timeline

4 comparable deals

Recent News